S-1/A: ARC Group Acquisition I Corp Files S-1/A for IPO of Units
Amendment to Registration Statement (S-1/A)
ARC Group Acquisition I Corp, a blank check company, filed an S-1/A for its initial public offering of 15 million units, each comprising one Class A ordinary share and one-half of a redeemable warrant, aiming to raise $150 million for a business combination.
Summary
- ARC Group Acquisition I Corp (formerly D. Boral ARC Acquisition II Corp.) is a newly formed British Virgin Islands blank check company (SPAC) with no operating history or revenues, established to pursue a business combination.
- The company plans an initial public offering (IPO) of 15,000,000 units at $10.00 per unit, totaling $150,000,000, with an over-allotment option for an additional 2,250,000 units.
- Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50.
- The sponsor, MFH 2, LLC, has committed to purchase 200,000 private units at $10.00 per unit for an aggregate of $2,000,000, which are non-redeemable and subject to transfer restrictions.
- Founder shares (Class B ordinary shares) were acquired by the sponsor for a nominal price of approximately $0.002 per share, leading to immediate and substantial dilution for public shareholders (approximately 99.1% or $9.91 per share).
- A significant portion of the IPO proceeds, $150,000,000, will be placed in a U.S.-based trust account, to be invested in U.S. government treasury obligations or money market funds.
- The company has 18 months from the IPO closing (with a potential 3-month sponsor extension, further extendable by shareholder approval) to complete a business combination, or public shares will be redeemed at approximately $10.00 per share, and warrants will expire worthless.
- The management team, including CEO Datuk Dr. Doris Wong Sing Ee and COO Ian Hanna, possesses extensive experience in M&A, investment banking, and prior SPAC transactions, with a focus on technology, healthcare, and logistics industries.
- The company aims to acquire businesses with an aggregate enterprise value of $700 million or greater, though smaller targets may be considered.
- As of September 30, 2025, the company reported a total shareholders deficit of $(41,400) and a net loss of $(41,400) for the period from inception (May 27, 2025) to September 30, 2025.
Sentiment
Score: 3
Explanation: The sentiment is cautious due to the inherent risks of a blank check company, significant potential for shareholder dilution, and notable conflicts of interest involving management and the underwriter. While the management team has experience, their prior SPACs showed very high redemption rates and poor post-merger stock performance, which is a major concern. The lack of operating history and reliance on future business combination success further contributes to the low score.
Positives
- The management team has over 60 years of combined expertise in private equity investing and investment banking, with a proven track record in SPAC transactions, including leading or advising on over $10 billion in SPAC IPO and de-SPAC transactions since 2021.
- The leadership team has successfully identified and closed two prior SPAC business combinations, demonstrating deal execution capabilities.
- The company leverages a robust network of relationships with private equity sponsors, venture capital firms, family offices, investment banks, and industry executives to generate proprietary deal flow.
- Management possesses global perspective and operational expertise across diverse international markets, having completed transactions in North America, Europe, Asia, and emerging markets.
- The company's structure as an existing public company offers a target business an alternative to a traditional IPO, potentially being more expeditious and cost-effective.
Negatives
- Public shareholders will experience immediate and substantial dilution of approximately 99.1% (or $9.91 per share) due to the sponsor's nominal purchase price for founder shares ($0.002 per share).
- The anti-dilution provisions for founder shares could result in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion, further diluting public shareholders.
- Conflicts of interest exist as the sponsor and management team own founder shares and private units, creating an incentive to complete a business combination even if it is unprofitable for public shareholders.
- Ian Hanna, the COO, is also CEO of ARC Group Securities (the underwriter) and an officer/director of two other blank check companies, creating potential conflicts in allocating business opportunities.
- The company has no operating history or revenues, making it a highly speculative investment.
- The company may not be able to complete a business combination within the specified timeframe (18-21 months), leading to liquidation and warrants expiring worthless.
- The ability of public shareholders to redeem shares for cash may make the company's financial condition unattractive to potential target businesses, limiting acquisition opportunities.
- The company's auditor, Guangdong Prouden CPAs GP, is headquartered in Guangzhou, China, which could lead to delisting under the Holding Foreign Companies Accountable Act if the PCAOB cannot inspect them for two consecutive years.
- The company's financial position as of September 30, 2025, shows a shareholders deficit of $(41,400) and no cash on hand.
Risks
- No operating history and no revenues, making it difficult to evaluate the ability to achieve business objectives.
- Public shareholders may not have an opportunity to vote on the proposed initial business combination, and even if a vote is held, founder share holders' participation may lead to approval despite public shareholder dissent.
- The only opportunity to affect investment decisions regarding a potential business combination may be limited to exercising redemption rights for cash.
- No minimum net tangible asset requirement, which could lead to securities being deemed penny stocks if delisted from Nasdaq.
- The ability of public shareholders to redeem shares for cash may make the financial condition unattractive to potential business combination targets.
- The ability of public shareholders to exercise redemption rights for a large number of shares may prevent the completion of the most desirable business combination or dilute investments.
- The requirement to complete a business combination within the completion window may give target businesses leverage in negotiations and limit due diligence time.
- Affiliates may purchase public shares or warrants, potentially influencing a vote on a proposed business combination and reducing the public float.
- No rights or interests in funds from the trust account, except under limited circumstances, forcing liquidation of investment by selling shares or warrants, potentially at a loss.
- Nasdaq may delist securities, limiting trading ability and subjecting the company to additional trading restrictions.
- The nominal purchase price paid by the sponsor for founder shares results in significant dilution to public shares and allows the sponsor to make substantial profit even if the stock price declines.
- Trading in securities may be prohibited under the Holding Foreign Companies Accountable Act if the PCAOB cannot inspect or fully investigate the auditor, leading to delisting.
- Past performance by the management team is not indicative of future performance.
- The company may be classified as a Passive Foreign Investment Company (PFIC), resulting in adverse U.S. federal income tax consequences to U.S. investors.
- Liquidation of trust account investments into cash to mitigate Investment Company Act risk could result in less interest earned and a lower redemption amount for public shareholders.
- Changes in laws or regulations, or failure to comply, may adversely affect the business and ability to complete a business combination.
- Global geopolitical conditions (Russia-Ukraine, Israel-Hamas, Israel-Iran conflicts) may materially adversely affect the search for a target business or the performance of a post-business combination company.
- Shareholders may be held liable for claims by third parties against the company to the extent of distributions received upon redemption of their shares.
- The company may not hold an annual general meeting until after the business combination, delaying shareholder interaction with management.
- The company may seek business combination opportunities in industries or sectors outside of management's expertise, increasing risk.
- The company is not required to obtain an independent fairness opinion for non-affiliated business combinations, relying solely on the board's judgment.
- Issuance of additional Class A ordinary shares or preference shares to complete a business combination or under an employee incentive plan could dilute existing shareholders.
- The company may issue shares to investors in connection with a business combination at a price less than the prevailing market price, causing dilution.
- The company is considered a 'controlled company' by Nasdaq due to Class B shareholders' voting rights on director appointments, potentially allowing reliance on exemptions from certain corporate governance requirements.
- Resources could be wasted researching uncompleted business combinations.
- Potential conflicts of interest due to management's involvement with other entities, including other SPACs.
- The letter agreement with the sponsor, officers, and directors may be amended without shareholder approval.
- Warrants may be redeemed prior to their exercise at a disadvantageous time, making them worthless.
- The warrant agreement designates New York courts as the exclusive forum for certain disputes, potentially limiting warrant holders' ability to obtain a favorable judicial forum.
- A provision in the warrant agreement may make it more difficult to consummate a business combination if certain equity issuances occur at a low price.
- The grant of registration rights to the sponsor and other holders of private units may adversely affect the market price of Class A ordinary shares.
- Cyber incidents or attacks could result in information theft, data corruption, operational disruption, and/or financial loss.
- Recent increases in inflation could make it more difficult to complete a business combination.
Future Outlook
The company is a blank check company with no current operations or revenues, and its future outlook is entirely dependent on its ability to successfully identify and complete an initial business combination within the specified timeframe. Management intends to focus on technology, healthcare, and logistics industries, leveraging its extensive experience and network. The company expects to incur increased expenses as a public company and will generate non-operating income from interest on funds held in the trust account. There is no assurance that a suitable target will be found or that a business combination will be successful or profitable for public shareholders.
Management Comments
- Management believes that the experience and capabilities of the management team will make the company an attractive partner to potential target businesses, enhance its ability to complete a successful business combination, and bring value to the business post-business combination.
- Management intends to focus on industries that complement the management team's background and capitalize on their ability to identify and acquire a business.
- Management believes that the network of contacts and relationships of the management team will provide important sources of investment opportunities.
- Management considers it likely that the board of directors will be able to make an independent determination of the fair market value of the initial business combination.
- Management does not believe that the fiduciary, contractual or other obligations or duties of officers or directors, or of any affiliates of initial shareholders, or policies applicable to any affiliates of initial shareholders, will materially affect the ability to complete an initial business combination, as other entities to which they owe duties are not themselves in the business of engaging in business combinations.
Industry Context
The company operates as a Special Purpose Acquisition Company (SPAC), a trend that has seen significant growth in recent years. The filing acknowledges increased competition for attractive targets due to the proliferation of SPACs and notes that many target businesses have underperformed financially post-business combination. The management team highlights its extensive experience in SPAC transactions and global capital markets, aiming to differentiate itself through a cultivated network and proprietary deal sourcing methodology. The focus on technology, healthcare, and logistics aligns with high-growth sectors often targeted by SPACs. However, the broader industry faces challenges from market volatility, geopolitical conditions, and increased regulatory scrutiny, including new SEC rules for SPACs.
Comparison to Industry Standards
- The company's unit structure, with one Class A ordinary share and one-half of one redeemable warrant, is designed to reduce the dilutive effect of warrants compared to some other SPACs that issue whole warrants, aiming to be a more attractive business combination partner.
- The company's initial listing standards on Nasdaq are expected to be met, but continued listing requires maintaining certain financial, distribution, and share price levels, which is a common challenge for SPACs post-IPO and de-SPAC.
- The company's management team has prior SPAC experience, including Energem Corp. (97.4% public share redemption), INFINT Acquisition Corporation (99% public share redemption), and Feutune Light Acquisition Corporation (99% public share redemption), where post-combination entities experienced significant share price declines and delistings, indicating a higher redemption rate and poorer post-merger performance compared to successful SPACs.
- The nominal purchase price paid by the sponsor for founder shares ($0.002 per share) is a common practice in the SPAC industry but results in significant dilution for public shareholders, a widely criticized aspect of SPACs.
- The company's auditor, Guangdong Prouden CPAs GP, is headquartered in China, which exposes the company to risks under the Holding Foreign Companies Accountable Act, a specific regulatory concern for companies with auditors in jurisdictions not fully inspected by the PCAOB, unlike many U.S.-based SPACs.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer and Executive Director | NA | Datuk Dr. Doris Wong Sing Ee | 2025-11-19 | Appointment to lead the company. |
| Chief Operating Officer and Executive Director | NA | Ian Hanna | 2025-11-19 | Appointment to lead the company. |
| Chief Financial Officer | NA | Kiu Cu Seng | 2025-11-19 | Appointment to lead the company. |
| Independent Director Nominee | NA | Dr. Satis Waran Nair Krishnan | NA | Nomination to the board. |
| Independent Director Nominee (Chair of Audit Committee) | NA | Inigo Angel Laurduraj | NA | Nomination to the board. |
| Independent Director Nominee (Chair of Compensation Committee) | NA | Soon Ping (Zara) Pappas | NA | Nomination to the board. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Structure | The board of directors will consist of five members and be divided into three classes with staggered three-year terms. Only Class B ordinary shareholders (the sponsor) will have the right to appoint and remove directors prior to the initial business combination. | Upon commencement of trading of units on Nasdaq | This structure concentrates control over director appointments with the sponsor until a business combination, potentially limiting public shareholders' influence. The company may be considered a 'controlled company' by Nasdaq, allowing it to elect not to comply with certain corporate governance requirements. |
| Committee Establishment | An audit committee and a compensation committee will be established upon the commencement of trading of units on Nasdaq. The audit committee will have three independent members, with Inigo Angel Laurduraj as chair and an audit committee financial expert. The compensation committee will also have independent members, with Soon Ping (Zara) Pappas as chair. | Upon commencement of trading of units on Nasdaq | These committees are standard for public companies and aim to enhance oversight of financial reporting, internal controls, and executive compensation, aligning with regulatory requirements. |
| Exclusive Forum Provision (British Virgin Islands) | The amended and restated memorandum and articles of association designate the courts of the British Virgin Islands as the exclusive forum for certain disputes related to shareholder shareholding, derivative actions, breach of fiduciary duty claims, and claims governed by the internal affairs doctrine. | Upon consummation of the offering | This provision could limit shareholders' ability to bring claims in U.S. federal courts, potentially increasing costs and discouraging lawsuits against the company or its management in forums perceived as more favorable to investors. |
| Exclusive Forum Provision (New York for Warrants) | The warrant agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain actions and proceedings initiated by holders of warrants. | Upon execution of Warrant Agreement | This provision aims to centralize litigation related to warrants in New York courts, potentially affecting warrant holders' choice of forum for disputes. |
| Code of Ethics | A Code of Ethics applicable to directors, officers, and employees will be adopted to promote honest and ethical conduct, disclosure, and compliance with laws and regulations. | Prior to consummation of the offering | This is a standard governance measure to establish ethical guidelines and accountability within the company. |
| Emerging Growth Company & Smaller Reporting Company Status | The company qualifies as an 'emerging growth company' and 'smaller reporting company,' allowing it to take advantage of certain exemptions from disclosure and accounting requirements. | Upon effectiveness of the offering | This status reduces reporting burdens but may make the company's securities less attractive to some investors and comparisons with other public companies more difficult due to differing accounting standards. |
Legal Proceedings
- No material litigation, arbitration, or governmental proceeding is currently pending against the company or any members of its management team in their capacities as such.
Related Party Transactions
- The sponsor, MFH 2, LLC, purchased 7,392,857 Class B ordinary shares for $25,000 (approximately $0.002 per share) and committed to purchase 200,000 private units for $2,000,000.
- Datuk Dr. Doris Wong Sing Ee, the CEO, owns approximately 92% of the equity of the sponsor and has majority voting and investment discretion over the sponsor's securities.
- Ian Hanna (COO), Kiu Cu Seng (CFO), Dr. Satis Waran Nair Krishnan (Independent Director), Inigo Angel Laurduraj (Independent Director), and Soon Ping (Zara) Pappas (Independent Director) will receive indirect interests in founder shares through membership interests in the sponsor.
- An affiliate of the sponsor will be reimbursed $20,000 per month for office space, utilities, and administrative support, commencing upon Nasdaq listing until a business combination or liquidation.
- The sponsor loaned the company up to $500,000 for offering-related and organizational expenses, which will be repaid from non-trust funds upon IPO closing. This promissory note was amended to extend the due date to December 31, 2026, and increase the principal to $500,000.
- The sponsor, its affiliates, or officers/directors may loan the company up to $2,500,000 for working capital to finance transaction costs, convertible into private units at $10.00 per unit at the lender's option.
- The company may pay finders, advisory, consulting, or success fees to the sponsor or management team members for services related to completing a business combination, payable from funds outside the trust account prior to a business combination.
- The audit committee will review all payments made to the sponsor, officers, directors, or their affiliates on a quarterly basis.
- Dr. Satis Waran Nair Krishnan and Inigo Angel Laurduraj, two independent director nominees, are married to one another, which is disclosed as a potential risk for business continuity if their personal relationship deteriorates.
Stakeholder Impact
- **Shareholders (Public)**: Face immediate and substantial dilution from founder shares, risk of warrants expiring worthless if no business combination, and potential for less than $10.00 per share upon liquidation if third-party claims deplete the trust account. Redemption rights are available but subject to limitations. Voting power on director appointments is limited until a business combination.
- **Shareholders (Sponsor/Insiders)**: Have significant control over the company's direction and director appointments. Benefit from founder shares acquired at a nominal price, creating a strong incentive to complete a business combination, even if it is not optimal for public shareholders. Their private units are non-redeemable and expire worthless if no business combination occurs.
- **Employees (Future)**: The company has no current employees. Post-business combination, new management may be unfamiliar with U.S. securities laws, potentially requiring time and resources for training. Key personnel of a target business may resign post-acquisition.
- **Customers/Suppliers (Future)**: The company's business strategy aims to identify targets with strong growth profiles and defensible market positions, potentially benefiting future customers and suppliers of the acquired entity. However, the lack of diversification in a single acquired business could expose them to industry-specific risks.
- **Creditors**: The trust account is designed to protect public shareholders' funds from creditor claims, but there is a risk that third-party claims not subject to waivers could reduce the amount available for redemption. The sponsor has agreed to indemnify the company against certain claims to protect the trust account, but its ability to satisfy these obligations is not independently verified.
Next Steps
- Complete the initial public offering of units.
- Apply to have units listed on The Nasdaq Global Market under the symbol ARBCU.
- File a Current Report on Form 8-K with the SEC, including an audited balance sheet reflecting gross proceeds from the IPO, to allow separate trading of Class A ordinary shares (ARBC) and warrants (ARBCW) on Nasdaq, expected on the 52nd day post-prospectus date or earlier with underwriter consent.
- Identify and acquire one or more businesses with an aggregate enterprise value of $700 million or greater within 18-21 months from the IPO closing.
- Establish and maintain an audit committee and compensation committee, composed entirely of independent directors as required by Nasdaq rules.
- Comply with internal control requirements of the Sarbanes-Oxley Act for the fiscal year ending December 31, 2026.
- Potentially seek shareholder approval to amend the amended and restated memorandum and articles of association to extend the business combination completion window if needed.
- Repay up to $500,000 in loans from the sponsor for offering-related and organizational expenses upon IPO closing.
- Begin paying an affiliate of the sponsor $20,000 per month for office space and administrative services upon Nasdaq listing.
Key Dates
| Date | Description |
|---|---|
| 2002-01-01 | Datuk Dr. Doris Wong Sing Ee started her career as a Managing Director at Niagamatic Sdn. Bhd. |
| 2005-01-01 | Inigo Angel Laurduraj served as an Auditor for Moore Stephens. |
| 2006-03-01 | Ian Hanna began his career in the automotive industry at General Motors. |
| 2007-01-01 | Inigo Angel Laurduraj served as a Senior Accounting Manager at IOI Oleochemicals Sdn. Bhd. |
| 2009-01-01 | Kiu Cu Seng earned a Diploma in Accounting from Kuala Lumpur Infrastructure University College. |
| 2010-01-01 | Soon Ping (Zara) Pappas earned a Certificate in Business Studies from Segi College, Kuala Lumpur, Malaysia. |
| 2010-10-01 | Dr. Satis Waran Nair Krishnan served as a Medical Officer for the Ministry of Health Malaysia. |
| 2011-01-01 | Ian Hanna earned a Master of Science in Automotive/Manufacturing Engineering from the University of Michigan. |
| 2012-01-01 | Datuk Dr. Doris Wong Sing Ee served as Strategic Business Consultant for JLPW Law Firm. |
| 2013-01-01 | Kiu Cu Seng graduated from Infrastructure University Kuala Lumpur with a bachelors degree (with Honors) in Accounting. |
| 2014-01-01 | Inigo Angel Laurduraj earned a Bachelors of Arts in Accounting. |
| 2015-01-01 | Datuk Dr. Doris Wong Sing Ee served as General Manager in Dai-Ichi Kikaku Sdn. Bhd. |
| 2015-01-01 | Inigo Angel Laurduraj earned an Association of Chartered Certified Accountants (ACCA). |
| 2016-01-01 | Datuk Dr. Doris Wong Sing Ee earned a Master of Corporate Governance from HELP University, Malaysia. |
| 2017-02-01 | Datuk Dr. Doris Wong Sing Ee has been a non-independent non-executive director at Trive Property Group Bhd. |
| 2019-01-01 | Datuk Dr. Doris Wong Sing Ee served as Chief Corporate Officer in Metronic Engineering Sdn. Bhd. |
| 2019-06-01 | Kiu Cu Seng held managerial roles at SBY & Partners PLT (formerly Siew Boon Yeong & Associates). |
| 2020-10-01 | Datuk Dr. Doris Wong Sing Ee has served as Executive Director of Metronic Global Bhd. |
| 2021-02-01 | Ian Hanna served as Chief Executive Officer of Giga Carbon Neutrality. |
| 2021-03-01 | Kiu Cu Seng has served as Group Accountant for Sanichi Technology Bhd and Trive Property Group Berhad and BCM Alliance Berhad. |
| 2021-08-12 | Kiu Cu Seng served as Energem Corp's Chief Financial Officer. |
| 2021-11-01 | Ian Hanna worked with ARC Group Limited as a Managing Director. |
| 2021-11-16 | Energem Corp's initial public offering. |
| 2022-08-01 | Energem Corp announced a definitive agreement for a business combination with Graphjet Technology. |
| 2022-09-01 | Kiu Cu Seng took on the role of Group Accountant at Computer Forms (Malaysia) Berhad. |
| 2023-01-27 | Datuk Dr. Doris Wong Sing Ee's appointment as Executive Director of Energem Corp. |
| 2023-09-01 | Dr. Satis Waran Nair Krishnan became a General Practitioner with Centric Health in Drogheda, Ireland. |
| 2023-09-01 | Soon Ping (Zara) Pappas worked as an occupational therapy practitioner on Long Island, New York. |
| 2024-01-01 | Soon Ping (Zara) Pappas earned an Associates Degree in Applied Science from Suffolk Community College (New York). |
| 2024-02-28 | Energem Corp held a special meeting of shareholders to approve the business combination with Graphjet Technology. |
| 2024-03-01 | Ian Hanna became a partner at ARC Group Limited. |
| 2024-03-05 | EDOC Acquisition Corp. shareholders approved the business combination with Australian Oilseeds Investments Pty Ltd. |
| 2024-03-14 | Energem Corp completed its business combination with Graphjet Technology Sdn. Bhd.; Graphjet's ordinary shares and warrants began trading on Nasdaq. |
| 2024-03-22 | Australian Oilseeds Holdings Limited began trading its ordinary shares and warrants on Nasdaq Global Market. |
| 2024-05-01 | Datuk Dr. Doris Wong Sing Ee served as the Executive Director of BSL Corporation Berhad. |
| 2024-06-17 | Feutune Light Acquisition Corporation held a special meeting of shareholders to approve the business combination with Thunder Power Holdings, Inc. |
| 2024-06-21 | Feutune Light Acquisition Corporation completed its initial business combination with Thunder Power Holdings, Inc. |
| 2024-08-01 | Ian Hanna served as Chief Executive Officer of ARC Group Securities. |
| 2024-08-06 | INFINT Acquisition Corporation held a special meeting of shareholders to approve the business combination with Seamless Group, Inc. |
| 2024-09-03 | INFINT Acquisition Corporation's business combination with Seamless Group, Inc. closed; CURRENC Group Inc. began trading on Nasdaq. |
| 2024-10-31 | Australian Oilseeds Holdings Limited transferred its listing to Nasdaq Capital Market. |
| 2025-01-06 | Datuk Dr. Wong served as a director of Graphjet until this date. |
| 2025-02-26 | Datuk Dr. Doris Wong Sing Ee became CEO and Executive Director of Bio Green Med Solution, Inc.; Kiu Cu Seng became CFO and Executive Director of Bio Green Med Solution, Inc. |
| 2025-04-01 | Dr. Satis Waran Nair Krishnan and Inigo Angel Laurduraj became directors of Bio Green Med Solution, Inc. |
| 2025-04-21 | Thunder Power Holdings, Inc. stock began trading on the OTC Pink Open Market under the symbol AIEV. |
| 2025-05-07 | MFH 2, LLC (the Sponsor) was formed. |
| 2025-05-27 | Company incorporated as a BVI business company; Sponsor purchased 12,321,429 Class B ordinary shares for $25,000; Inception date for financial statements. |
| 2025-06-04 | Sponsor issued an unsecured promissory note to the Company for up to $350,000 for offering costs; advance from related party charged to promissory note. |
| 2025-06-05 | Thunder Power Holdings, Inc. stock started trading on the OTCQB Venture Market. |
| 2025-09-01 | Soon Ping (Zara) Pappas became a director of Bio Green Med Solution, Inc. |
| 2025-09-21 | Arc Group International Ltd. sold approximately 92% of its equity membership interests in the sponsor to Datuk Dr. Doris Wong Sing Ee. |
| 2025-09-30 | Unaudited balance sheet date. |
| 2025-11-13 | Graphjet Technology's ordinary shares began trading on the OTC Markets under the ticker symbol GTIJF. |
| 2025-11-19 | Datuk Dr. Doris Wong Sing Ee became CEO and Executive Director; Ian Hanna became COO and Executive Director; Kiu Cu Seng became CFO. |
| 2025-11-26 | Company changed its name from D. Boral ARC Acquisition II Corp. to ARC Group Acquisition I Corp. |
| 2025-11-28 | Promissory Note amended to extend payable date to December 31, 2026, and increase aggregate principal amount to $500,000. |
| 2025-12-03 | Sponsor surrendered 4,928,572 Class B ordinary shares for no consideration due to a downsize of the proposed public offering. |
| 2025-12-04 | Consent to be Named as a Director Nominee for Dr. Satis Waran Nair Krishnan, Inigo Angel Laurduraj, and Soon Ping (Zara) Pappas. |
| 2025-12-08 | Closing sale prices for GTIJF ($2.29), CURR ($2.33), AEIV ($0.22), COOT ($0.81), and COOTW ($0.239) reported. |
| 2025-12-10 | Date of S-1/A filing and audit report. |
| 2026-12-31 | Extended payable date for the Promissory Note from the Sponsor. |
Recommendation
sellThe filing reveals significant red flags for investors. The immediate and substantial dilution of 99.1% for public shareholders due to the sponsor's nominal purchase price for founder shares is highly unfavorable. Furthermore, the historical performance of SPACs involving the management team shows extremely high redemption rates (97-99%) and subsequent poor stock performance, including delistings, which strongly suggests a pattern of value destruction for public investors. The numerous conflicts of interest, including the COO's role as CEO of the underwriter and involvement in other SPACs, create a strong incentive for management to complete *any* business combination, regardless of its long-term viability for public shareholders. The risk of delisting due to the auditor's location in China under the HFCAA adds another layer of uncertainty. Given these factors, the risk-reward profile is heavily skewed against public investors, making a 'sell' recommendation appropriate for those considering this offering.
Keywords
SPAC, Blank Check Company, IPO, Units, Class A Ordinary Shares, Warrants, Business Combination, Acquisition, Dilution, Trust Account, Redemption Rights, Corporate Governance, SEC Filing, Nasdaq Listing, Risk Factors, Financial Reporting, MFH 2 LLC, ARC Group Securities LLC, Datuk Dr. Doris Wong Sing Ee, Ian Hanna, Kiu Cu Seng, Emerging Growth Company, Smaller Reporting Company, Holding Foreign Companies Accountable Act, PFIC, Related Party Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.